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Background: Human Langerhans cells (LCs) reside in foreskin and vaginal mucosa and are the first immune cells to
interact with HIV-1 during sexual transmission. LCs capture HIV-1 through the C-type lectin receptor langerin, which
routes the virus into Birbeck granules (BGs), thereby preventing HIV-1 infection. BGs are langerin-positive organelles
exclusively present in LCs, however, their origin and function are unknown.
Results: Here, we not only show that langerin and caveolin-1 co-localize at the cell membrane and in vesicles but
also that BGs are langerin/caveolin-1-positive vesicles are linked to the lysosomal degradation pathway in LCs.
Moreover, inhibition of caveolar endocytosis in primary LCs abrogated HIV-1 sequestering into langerin+ caveolar
structures. Notably, both inhibition of caveolar uptake and silencing of caveolar structure protein caveolin-1 resulted
in increased HIV-1 integration and subsequent infection. In contrast, inhibition of clathrin-mediated endocytosis did
not affect HIV-1 integration, even though HIV-1 uptake was decreased, suggesting that clathrin-mediated endocytosis is
not involved in HIV-1 restriction in LCs.
Conclusions: Thus, our data strongly indicate that BGs belong to the caveolar endocytosis pathway and that caveolin-1
mediated HIV-1 uptake is an intrinsic restriction mechanism present in human LCs that prevents HIV-1 infection.
Harnessing this particular internalization pathway has the potential to facilitate strategies to combat HIV-1 transmission.
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Langerhans cells (LCs) are a specialized subset of anti-
gen presenting cells in the epidermis of the skin and
mucosal tissues of the vagina and foreskin. They provide
a barrier against entry of pathogens, thereby protecting
against disease [1-3]. Due to their location, LCs are
among the first immune cells that encounter HIV-1 in
genital tissue during sexual transmission [4,5]. LCs are
not efficiently infected with HIV-1 and do not transmit
virus to T cells [3]. However, Toll-like receptor activation
and high viral loads enhance HIV-1 transmission by hu-
man LCs [6-8]. LCs express the C-type lectin receptor
(CLR) langerin that captures HIV-1, which is subse-
quently internalized into Birbeck granules (BGs), where* Correspondence: t.b.geijtenbeek@amc.uva.nl
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about the function of BGs and how it contributes to lim-
iting HIV-1 infection. Although conflicting theories exist
regarding the origin and function of BGs [9], it is clear
that the expression of functional langerin is a prerequis-
ite for the formation of BGs [10,11]. Ectopic expression
of langerin in cell lines induces BG formation and anti-
bodies against langerin are internalized into BGs [12,13].
Langerin-mediated internalization is thought to occur
through classical clathrin-coated endosomal uptake [14].
However, the cytoplasmic domain of langerin does not
contain ‘classic’ internalization motifs that are associated
with clathrin binding or formation of the coated pits,
such as a double-tyrosine or tri-leucine motif [10,15,16].
In addition, BGs have been proposed to be subdomains
of the endosomal recycling compartment and recent
studies show that caveolin-1 not only overlaps with
endocytic recycling compartments in epithelial cells but
also contributes to LCs ability to cross-present antigens
to CD8+ T cells. [14,17,18]. HIV-1 internalization intoentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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investigated the internalization route of HIV-1 and the
role of caveolin-1 dependent internalization in protection
against HIV-1 infection in LCs. Here, we show that
BGs are caveolin-1-positive vesicles and that caveolin-1
prevents HIV-1 infection in human Langerhans cells.
Results and discussion
Langerin co-localizes with caveolin-1
Lipid raft internalization is the major internalization
route besides clathrin-mediated endocytosis. Caveolar
internalization occurs via lipid rafts and is dependent
on the integral membrane molecule caveolin-1 [19,20].
Caveolae are small cholesterol-rich invaginations in the
plasma membrane that can form caveolar vesicles
[21,22], which fuse with late endosomes and lysosomes
[23]. We investigated whether langerin co-localized
with the major caveolar structural protein caveolin-1 in
primary human LCs, MUTZ3-derived LC cells (MUTZ-
LCs) and a langerin-transduced cell line (THP-lan-
gerin). Under steady-state conditions, caveolin-1 and
langerin partially co-localized in THP-langerin, MUTZ-
LCs as well as in primary LCs as shown by confocal
immunofluorescence microscopy (Figure 1A,B,C). To
further investigate co-localization in lipid rafts we per-
formed co-immunoprecipitation assays from lysates of
primary LCs. Caveolin-1 co-immunoprecipitated with
langerin and vice versa (Figure 1D), supporting our im-
aging data that langerin and caveolin-1 co-localize
in LCs.
HIV-1 uptake by LCs depends on caveolin-1
Langerin expressed by LCs captures HIV-1 for internal-
ization into BGs [3]. We therefore investigated whether
caveolin-1-mediated internalization is involved in HIV-1
uptake using filipin, an inhibitor of caveolar uptake
[24,25]. Filipin impairs caveolae invaginations and caveo-
lar endocytosis [26-28]. Primary LCs were incubated
with HIV-1 for 4 hours and internalization was assessed
by confocal immunofluorescence microscopy. Our data
show that internalized HIV-1 partly co-localized with
langerin as well as caveolin-1 (Figure 2A). Notably, our
data suggest that HIV-1 uptake is mediated by caveolar
endocytosis, since we observed increased HIV-1 staining
at the cell-surface and less intracellular HIV-1 in the
presence of filipin (Figure 2B). Filipin treatment in-
creased surface expression of langerin (Additional file
1a, b), strongly supporting a role for caveolin-mediated
uptake in langerin trafficking. Next, we quantified HIV-1
uptake by flow cytometry. LCs were incubated with
HIV-1 for 4 hours and cell-surface bound HIV-1 was re-
moved by trypsin. LCs efficiently internalized HIV-1
since trypsin treatment did not affect HIV-1 staining
(Figure 2C). Filipin treatment increased HIV-1 bindingto LCs compared to untreated LCs (Figure 2C), which
might be due to increased expression of langerin on the
cell-surface due to inhibition of caveolin-mediated endo-
cytosis (Additional file 1a, b). Notably, filipin treatment
significantly decreased HIV-1 internalization by LCs, since
removal of surface-bound virions from filipin-treated LCs
by trypsin significantly decreased HIV-1 staining com-
pared to untreated LCs. These data strongly support a role
for caveolin-mediated endocytosis of HIV-1 by LCs. These
data strongly suggest that caveolin-1 is necessary for
langerin-mediated HIV-1 internalization by LCs.
Birbeck granules belong to the caveolar endocytosis
pathway
We have previously shown that HIV-1 is internalized via
langerin into BGs in primary LCs [3]. BGs have been de-
scribed as rod-shaped structures of variable length with
periodically striated lamellae (Figure 3A). Although BGs
are suggested to be involved in HIV degradation [3], the
exact function of BGs in this process remains unclear.
Based on our data, we hypothesized that BGs are part of
the caveolin-mediated internalization pathway. We
therefore used immuno-transmission electron micros-
copy to investigate whether caveolin-1 is present in BGs.
Because of the paucity in primary LCs we used MUTZ-
LCs that have high levels of langerin similar to primary
LCs and have been validated as a bona fide LC model
[3,29]. MUTZ-LCs expressed high levels of the tennis
racquet shaped BGs (Figure 3A, empty arrow heads).
Furthermore, depending on the interface and cutting
surface, some BGs appeared tubular (Figure 3A, filled
arrow heads). BGs originated as invagination in the cell
membrane and stained langerin-positive (Figure 3B,
filled arrow heads). We noted in particular that caveolin-
1 was present in the invaginations of the cell membranes
that form BGs (Figure 3C, left panel, filled arrow head).
Caveolin-1 was abundant in BGs (Figure 3C, middle
panels), which were also positive for langerin (Figure 3B)
and appear either tubular (Figure 3B,C) or tennis rac-
quet shaped (Figure 3B right panel). In addition, co-
localization of langerin and caveolin-1 was observed not
only along the BGs originated as invaginations of the cell
membrane but also along the more intracellular BGs
(Figure 3D). These data strongly suggest that langerin-
mediated internalization into BGs forms part of the
caveolar endocytosis pathway. Moreover, caveolin-1 was
present in multilaminar lysosomal structures in MUTZ-
LCs (Figure 3C, right panel, empty arrow head), which is
consistent with previous reports showing that caveolin-1
is targeted via late endosomes to lysosomes for degrad-
ation [23]. HIV-1 is taken up via langerin into BGs,
which is involved in protection against HIV-1 infection
[3,29]. However, the fate of the internalized HIV-1 is un-
clear. MUTZ-LCs were therefore incubated for 24 hours
Figure 1 Langerin co-localizes with caveolin-1 in steady state. Confocal scanning laser microscopic analyses for THP-langerin cell line (A),
MUTZ3-LC cell line (MUTZ-LCs, B) and human LCs (C) for langerin and caveolin-1 in steady-state condition in permeablized cells; bars represent
10 μm (A, B, C). Langerin and caveolin-1 were immuno-precipitated from LC cell lysates and immuno-blotted with antibodies against caveolin-1
or langerin (D). These data are representative of at least 3 donors or 3 independent experiments.
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gated by staining for lysosomal-associated membrane
protein 2 (LAMP2) and the lysosomal tetraspanin CD63.
Twenty-four hours post-infection, HIV was observed in
LAMP2/CD63 lysosomal vesicles (Figure 3E all panels)
suggesting that HIV-1 internalization into BGs intersects
the caveolin-1 degradation pathway [23] in LCs.
Caveolar uptake prevents HIV-1 infection
To further elucidate the caveolin-mediated restriction
mechanism, we investigated whether routing of HIV-1
into BGs via caveolar internalization specifically inhibits
early steps of HIV-1 infection. HIV-1 fusion with the cell
membrane and subsequent integration into the hostgenome are the first steps in HIV-1 infection [30]. We
measured HIV-1 fusion to the host membrane 2 hours
post-infection using BlaM assay [31] and HIV-1 integra-
tion into the genome 6 or 18 hours post-infection using
an Alu-PCR integration assay [32]. Blocking caveolar up-
take with filipin did not affect HIV-1 fusion (Figure 4A).
In contrast, integration of HIV-1 DNA into the host
genome increased by blocking caveolar uptake with fili-
pin already at 6 hours post-infection (Additional file 2a),
which further expanded to a more than 2-fold increase
in integration at 18 hours post-infection (Figure 4B).
The increase of HIV-1 integration by filipin treatment
was also observed when higher viral loads were used
(Additional file 2b). As a control, integration of VSV-G-
Figure 2 Langerin, caveolin-1 and HIV-1 partly co-localize in the same organelle. LCs were incubated with HIV-1 for 4 h in the absence
(A) or presence of the caveolar inhibitor filipin (1 μg/ml, B) LCs were stained for p24-HIV-1, langerin and caveolin-1; representative for 3 donors;
bars represent 10 μm (A, B). LCs were incubated with HIV-1 for 4 h in the absence or presence of filipin (1 μg/ml). Cells were treated with
Trypsin-EDTA (0.05%) or left untreated as control. HIV-1 uptake was quantified by permeabilizing cells and measuring subsequent HIV-1-p24
content by flow cytometry. n = 3 paired students t-test; *p < 0.05; SD and mean are depicted (C).
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langerin, was not affected by the presence of filipin showing
that filipin inhibitor did not interfere with the integration
process (Figure 4C). To further confirm the contribution of
caveolin-1 to the restriction of HIV-1 integration upon
caveolar-mediated uptake, we silenced caveolin-1 by RNA
interference (Additional file 2c). Similarly to inhibition of
caveolar uptake by filipin, HIV-1 integration was increased
after silencing of caveolin-1 (Figure 4D). Furthermore,
this increase of HIV-1 integration was accompanied by an
increase of HIV-1 infection (Figure 4E). Notably, our data
indicate that caveolin-1 mediated internalization restricts
HIV-1 infection at a post-entry/pre-integration stage of
the HIV-1 cycle in human LCs.BGs, which partly overlaps with the endosomal recyc-
ling pathway [33,34], have been thought to be part of
the clathrin-mediated endosomal recycling pathway
[12,14]. Therefore, we treated LCs with the clathrin in-
hibitor monodansylcadaverine (MDC). Inhibition of
clathrin-mediated uptake decreased HIV-1 uptake, sug-
gesting that both caveolin- and clathrin-mediated endo-
cytosis are involved in HIV-1 uptake. Strikingly, inhibition
of clathrin- in contrast to caveolin-mediated uptake did
not affect HIV-1 integration even when higher viral loads
were used (Figure 4B,F,G; Additional file 2b). These data
suggest that HIV-1 uptake is dependent on both caveolin-
and clathrin-mediated endocytosis, but only caveolin-mediated
endocytosis restricts HIV-1 infection.
Figure 3 Langerin and caveolin-1 are present in Birbeck Granules. MUTZ-LCs were analyzed by immuno-electron microscopy for the
presence of BGs that appear tubular (filled arrows) or tennis racquet shaped (A). Sections were stained for langerin with 10 nm gold particles
(B), caveolin-1 with 10 nm gold particles (C), langerin and caveolin with 10 nm and 15 nm gold particles, respectively (D). MUTZ-LCs were
incubated for 24 hours with HIV-1 and stained for p24-HIV-1 and CD63 or LAMP2 with 10 nm and 15 nm gold particles (E). Bars represent
200 nm and these data are representative of two independent experiments.
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Figure 4 Inhibition of caveolar uptake increased HIV-1 infection. LCs were incubated for 2 hours with HIV-1NL4.3/Vpr-BlaM and viral fusion
to the host membrane was measured by BlaM assay as described by [31] (A). MUTZ-LCs were incubated with HIV-1 NL4.3-BaL (MOI = 0.2, B) or
with VSV-G pseudotyped HIV-1 (MOI = 0.2, C) in the absence or presence of filipin (1 μg/ml) and integration of HIV-1 DNA was analyzed by
Alu-PCR. MUTZ-LCs were treated with small interfering RNA (siRNA) of caveolin-1-specific (Cav-1 siRNA) or with non-target control (Control siRNA).
Cells were incubated for 18 hours with HIV-1 NL4.3-BaL (D) or HIV-1 NL4.3 (E). Integration of HIV-1 DNA was determined by Alu-PCR. At day 8
post-infection, HIV-1 infection was measured by intracellular p24 staining. Percentage of CD1a+p24+ cells are depicted here as % of HIV-1
infection. MUTZ-LCs were incubated with HIV-1 for 4 h in the absence or presence of the clathrin inhibitor monodansylcadaverine (MDC, 10 or
50 μM). Cells were treated with Trypsin-EDTA (0.05%) or left untreated as control. HIV-1 uptake was quantified by permeabilizing cells and measuring
subsequent HIV-1-p24 content by flow cytometry (F). MUTZ-LCs were incubated for 18 hours with HIV-1 NL4.3-BaL in the absence or presence of
monodansylcadaverine (MDC, 10 or 50 μM) and integration of HIV-1 DNA was analyzed by Alu-PCR (G). n = 3 paired students t-test; *p < 0.05; SD and
mean are depicted (A, B, F, G). One representative experiment out of two is shown (C). n = 4 paired students t-test; *p < 0.05; SD and mean are
depicted (D, E).
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BGs originate at the cell membrane as langerin+caveolin-1+
caveolae and subsequently develop into caveolin-1-positive
BGs. Both caveolin and clathrin-mediated endocytosis path-
ways are involved in HIV-1 uptake, however, routing of
HIV-1 via caveolar internalization into BGs appears to
particularly contribute to the antiviral function of BGs
and langerin.Conclusions
Altogether, these data strongly indicate an important
protective role for caveolar uptake and for the caveolar
protein caveolin-1 in limiting HIV-1 infection in LCs.
Furthermore, our data show that BGs belong to the
caveolar endocytocis pathway and are involved in HIV-1
degradation. Co-infections by sexually transmitted dis-
eases alter the functionality of langerin and increase
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HIV-1 transmission to T cells. Novel strategies that
strengthen caveolar endocytosis pathway and langerin
function have the potential to prevent sexual transmis-
sion of HIV-1.Methods
Antibodies and reagents
The following antibodies were used: Rabbit-anti-
Caveolin-1 (Cell Signalling); Goat-anti-langerin (R&D);
DCGM4-PE (mouse-anti-langerin; Beckman Coulter);
KC57-RD1-PE (mouse-anti-p24; Beckman Coulter);
mouse-anti-CD1a-FITC (BD Pharmingen); anti-LAMP2
(Abcam); anti-CD63 (BD); sheep-anti-p24 (Aalto); 10E2
(anti-langerin [3]); 10E2 coupled to Alexa-647 (Alexa-647
labeling kit); Streptavidin-Alexa-488; Goat-anti-Mouse
IgG1 Alexa 546; Goat-anti-Rabbit Alexa 488 (5 μg/ml, all
Invitrogen); 15 nm protein A-gold; 10 nm protein G-gold
(both Aurion); prot A/G plus agarose beads (Santa Cruz);
filipin complex (Sigma Aldrich); Dispase II (Roche Diag-
nostics); monodansylcadaverine (Sigma Aldrich).Donors and cells
Human skin tissue was obtained from healthy donors
undergoing corrective breast or abdominal surgery after
informed consent in accordance with our institutional
guidelines. Split-skin grafts of 0.3 mm were harvested
using a dermatome (Zimmer). The slides were incubated
with Dispase II (1 U/ml) for 1 hour at 37°C and subse-
quently the epidermis was mechanically separated from
the dermis. Migratory LCs were generated by floating the
epidermis onto Iscoves Modified Dulbeccos’s Medium
(IMDM) supplemented with 10% FCS, gentamycine
(20 μg/ml, Centrafarm), pen/strep (10 U/ml and 10 μg/ml,
respectively; Invitrogen) for 2 days. The emigrated cells
were layered on a Lymphoprep (1.077 g/ml, Axis-shield)
gradient and were routinely 95% pure and expressed high
levels of langerin and CD1a. THP-langerin and the CD34+
human AML cell line MUTZ3 (MUTZ-LCs) were gener-
ated and cultured as described before [3].Viruses and infection
HIV-1 NL4.3-BaL, HIV-1 NL4.3, HIV-1 NL4.3/Vpr-
BlaM and single round VSV-G pseudotyped virus were
generated as previously described [6]. MUTZ-LCs
were infected at a multiplicity of infection of 0.2 or 0.6
(Additional file 2). MUTZ-LCs infection was assessed
by flow cytometry at day 8 post-infection by intracellu-
lar p24 staining. Double staining with CD1a (LCs
marker) and p24 was used to discriminate the percent-
age of CD1a+p24+ infected LCs.Electron microscopy
MUTZ-LCs (3x106) were fixed in 4% paraformaldehyde in
0.1 M phosphate buffer for 1 h at room temperature. Cells
were pelleted in 12% gelatine, cryoprotected in 2.3 M su-
crose and snap-frozen in liquid nitrogen. Ultrathin cryo-
sections were immunolabeled with Rabbit-anti-Caveolin-1
or Goat-anti-langerin antibody (10 nm protein G gold
label; 15 nm potein A gold label). After incubation, the
sections were stained with uranylacetate and embedded in
1% methylcellulose. Sections were examined with a trans-
mission electron microscope.
HIV-1 integration Alu-PCR assay
Total cell DNA was isolated at 6 or 18 hours after infec-
tion (multiplicity of infection 0.2) with a QIAamp blood
isolation kit (Qiagen) and a two-step Alu-LTR polymer-
ase chain reaction (PCR) was used to quantify the inte-
grated HIV-1 DNA in infected cells as previously
described [32] .In the first round of PCR, the DNA se-
quence between HIV-1 LTR and the nearest Alu repeat
was amplified with an HIV-1-specific primer (LTR R re-
gion) in combination with a primer that anneals to the
abundant genomic Alu repeats. The HIV-1-specific pri-
mer was extended with a marker region at the 5’ end,
which was used for specificity in the second-round
nested real-time quantitative PCR (RT-qPCR). The sec-
ond round specifically amplified the PCR products from
the first-round PCR using primers annealing to the
aforementioned marker region in combination with an-
other HIV-1-specific primer (LTR U5 region). Primer
sequences were as follows: first round PCR, HIV-1 LTR
R forward, 5’-ATGCCACGTAAGCGAAACTGCTGG
CTAACTAGGGAACCCACTG-3’ (marker sequence
in italic); Alu reverse, 5’-TCCCAGCTACTGGGGA
GGCTGAGG-3’; second-round RT-qPCR marker for-
ward, 5’-ATGCCACGTAAGCGAAACTG-3’; HIV-1
LTR U5 reverse, 5’-CACACTGACTAAAAGGGTCTG
AGG-3’. Two different dilutions of the PCR products
from the first-round of PCR were assayed to ensure that
PCR inhibitors were absent. For monitoring the signal
contributed by unintegrated HIV-1 DNA, the first-
round PCR was also performed using the HIV-1-
specific primer (LTR R region) only. HIV-1 integration
was normalized to GAPDH DNA levels and the results
for integration are shown relative to the HIV-infected
sample.
RNA interference
MUTZ-LCs were transfected with 50 nM siRNA with
the transfection reagent DF1 (Dharmacon) and were
used for experiments 72 h after transfection. The siRNA
was specific for Caveolin-1 (M-003467-01; SMARTpool;
Dharmacon) and nontargeting siRNA (D-001206-13;
Dharmacon) served as control. Silencing of caveolin-1
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Figure 2b). Primer sequences were as follows: caveolin-1
forward, 5’-TTTACCGCTTGCTGTCTGCC-3’; caveolin-
1 reverse, 5’- GGTACAACTGCCCAGATGTGC -3’; β-
actin forward, 5’-GCTCCTCCTGAGCGCAAG-3’ β-actin
reverse, 5’- CATCTGCTGGAAGGTGGACA-3’.
HIV-1 uptake
Cells were incubated for 4 hours with HIV-1 NL4.3
(multiplicity of infection 0.2) in the presence or absence
of filipin (1 μg/ml) or monodansylcadaverine (MDC, 10
or 50 μM). Cells were treated with Trypsin-EDTA
(0.05%; Invitrogen) or left untreated as control. Cell were
fixed with 4% paraformaldehyde and permeabilized with
PBS/ 0.5% saponin/1% BSA. Cells were incubated with dir-
ectly labeled antibody against HIV-1 p24 capsid protein
(10 μg/ml) in saponin buffer at 4°C for 30 minutes and
samples were analyzed on FACScanto (BD Biosciences).
Langerin staining
Cells were incubated for 4 hours with filipin (1 μg/ml)
or monodansylcadaverine (MDC 50 μM) or left un-
treated as control. To determine langerin surface ex-
pression, cells were incubated with directly labeled
antibody against langerin DCGM4-PE (mouse-anti-lan-
gerin; Beckman Coulter) in dPBS/1% BSA buffer at 4°C
for 30 minutes and samples were analyzed on FACScanto
(BD Biosciences). To determine langerin total expression,
cells were fixed with 4% paraformaldehyde, permeabilized
with dPBS/0.5% saponin/1% BSA. Cells were incubated
with directly labeled antibody against langerin in dPBS/
0.5% saponin/1% BSA at 4°C for 30 minutes and samples
were analyzed on FACScanto.
Confocal microscopy
Cells were incubated for 4 hours with HIV-1 NL4.3-BaL
(multiplicity of infection 0.5) in the presence or absence
of filipin (1 μg/ml), followed by fixation with 4% parafor-
maldehyde and permeabilization with PBS/ 0.1% saponin/
1% BSA. Cells were incubated with primary antibody
(5 μg/ml) at 4°C for 30 minutes and were subsequently
washed 3 times. Then cells were incubated with secondary
antibody at 4°C for 30 minutes, washed 3 times, and nuclei
were counterstained with Hoechst (10 μg/ml; Invitrogen).
Cells were plated onto poly-L-lysine coated slides and sin-
gle plane images were obtained by a confocal scanning
laser microscope (Zeiss).
Immunoprecipitation and immunoblotting
Whole cell extracts were prepared using RIPA lysis buffer
(Cell Signalling). Caveolin and Langerin were immunopre-
cipitated from 40 μg of extract with anti-Caveolin (Cell
Signalling) and 10E2 (anti-langerin [3]) on protein A/G
PLUS agarose beads (Santa Cruz). Lysates were resolvedby SDS-PAGE, and detected by immunoblotting with
Goat-anti-langerin or Rabbit-anti-Caveolin-1 antibodies.
This was followed by incubation with HRP-conjugated
secondary antibody (Thermo Scientific) and ECL detec-
tion (Thermo Scientific).
Statistical analysis
A paired Student’s t-test was used to evaluate the differ-
ences of at least 3 donors between filipin-treated or MDC-
treated and untreated or between caveolin-1 siRNA
treated and control siRNA treated. p < 0.05 was considered
significant.Additional files
Additional file 1: Filipin treatment increased langerin surface
expression. Primary LCs were incubated for 4 h with the caveolar
inhibitor filipin (1 μg/ml) or the clathrin inhibitor monodansylcadaverine
(MDC, 50 μM). Cells were stained for langerin without or with cell
permeabilization and surface langerin expression or total langerin
expression was determined, respectively, by flow cytometry (FI,
fluorescent intensity). One representative experiment out of three is
shown (A). Langerin expression presented relative to langerin surface
expression in unstimulated cells, set as 1. n = 3 paired students t-test;
*p < 0.05; SD and mean are depicted (B).
Additional file 2 Inhibition of caveolar uptake increased HIV-1
integration early post-infection and when using high HIV-1 titers.
MUTZ-LCs were incubated for 6 hours with HIV-1 NL4.3-BaL (MOI = 0.2)
and integration of HIV-1 DNA was analyzed by Alu-PCR (A). MUTZ-LCs were
incubated for 18 hours with higher MOI of HIV-1 NL4.3-BaL (MOI = 0.6) and
blocking caveolar uptake induced increase of HIV-1-integration. (B) Silencing
of caveolin-1 was verified by quantitative real-time PCR at 72 h after
transfection (C). Caveolin-1 mRNA levels was normalized to β-actin mRNA
levels and the results are shown relative to the control siRNA-treated sample.
n = 4 paired students t-test; *p < 0.05; SD and mean are depicted. One
representative experiment out of two is shown (A B).Abbreviations
LCs: Langerhans cells; BGs: Birbeck granules; CLR: C-type lectin receptor;
MUTZ-LCs: MUTZ3 (CD34+ human AML cell line) - derived LCs;
MDC: Monodansylcadaverine.
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